Parkinson's Disease and Movement Disorders
The Parkinson's Disease and Movement Disorders Program diagnoses and treats movement disorders including Parkinson's and Huntington's Diseases, Essential and Familial Tremor, Tourette's Syndrome, Parkinsonian Syndromes and Dystonic Disorders. Treatment Advances: The Parkinson's Disease Movement Disorders Program (PDMDP) director has participated in major clinical trials for the treatment of Parkinson's disease (PD) including trials of neuroprotective and novel therapeutic agents. Recent advances in medical management of early Parkinson's include once-daily therapies. Newly released and investigational agents offer significant treatment options for patients experiencing limited response to their current medications.
For those patients inadequately treated with pharmacological therapies, surgically effective treatment for tremors and Parkinson’s disease may be available through the use of Deep Brain Stimulation through the joint effort of the PDMDP and regional neurosurgical centers of excellence. Finally, intramuscular injection of botulinum toxin has demonstrated proven effectiveness for the treatment of dystonic disorders including torticollis, focal dystonia, and blepharospasm.